
Unitas Pharmaceuticals Private Limited
Manufacturer of GMP certified healthcare products including tablets, capsules, syrups, and more.
Manufacturer of GMP certified healthcare products including tablets, capsules, syrups, and more.
Unitas Pharmaceuticals Private Limited (UPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 02 March 1994 and has a history of 31 years. Its registered office is in Central Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 5.21 M.
The company currently has active open charges totaling ₹5.13 Cr. The company has closed loans amounting to ₹1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Neelam Nijhawan and Akhilesh Nagar serve as directors at the Company.
Central Delhi, Delhi, India
+91-XXXXXXXXXX
U74899DL1994PTC057671
057671
Private Limited Indian Non-Government Company
02 Mar 1994
29 Sep 2023
31 Mar 2023
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Neelam Nijhawan ![]() | Director | 14-Jan-2001 | Current |
Akhilesh Nagar ![]() | Director | 02-Mar-1994 | Current |
Unitas Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3% decrease. The company also saw a substantial improvement in profitability, with a 180.07% increase in profit. The company's net worth Soared by an impressive increase of 126.54%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Unitas Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Akhilesh Nagar is a mutual person
₹51.30 M
₹1.00 M
Date | Lender | Amount | Status |
---|---|---|---|
24 May 2023 | Hdfc Bank Limited | ₹2.43 M | Open |
30 Jul 2013 | Others | ₹2.74 Cr | Open |
02 Apr 2003 | State Bank Of India | ₹2.15 Cr | Open |
28 Sep 1999 | Bank Of India | ₹0.25 M | Satisfied |
28 Sep 1999 | Bank Of India | ₹0.75 M | Satisfied |
Unlock and access historical data on people associated with Unitas Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Unitas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unitas Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Unitas Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
A charge with Hdfc Bank Limited amounted to Rs. 2.43 M with Charge ID 100755689 was registered on 24 May 2023.
Unitas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
A charge with Others of Rs. 27.37 M registered on 30 Jul 2013 with Charge ID 10450560 was modified on 07 Aug 2020.
A charge with Others amounted to Rs. 27.37 M with Charge ID 10450560 was registered on 30 Jul 2013.
A charge with State Bank Of India of Rs. 21.50 M registered on 02 Apr 2003 with Charge ID 90058088 was modified on 26 Mar 2011.
Unitas Pharmaceuticals Private Limited was incorporated on 02 Mar 1994.
The authorized share capital of Unitas Pharmaceuticals Private Limited is ₹ 6.00 M and paid-up capital is ₹ 5.21 M.
Currently 2 directors are associated with Unitas Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Unitas Pharmaceuticals Private Limited is R-28, Inderpuri India, New Delhi, 110012.
The corporate identification number (CIN) of Unitas Pharmaceuticals Private Limited is U74899DL1994PTC057671 and the company number is 057671 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Unitas Pharmaceuticals Private Limited has fallen by -3.00%.
The financial reports for the fiscal year 2023 indicates that The net worth of Unitas Pharmaceuticals Private Limited has experienced an upsurge of 126.54%.
As per the financial statements for fiscal Year 2023, The total open charges for Unitas Pharmaceuticals Private Limited amount to ₹ 5.13 Cr.
The most recent Balance Sheet for Unitas Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.